New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - fluticasone propionate 0.5 g/kg ((micronised)) - nasal spray solution - 50 mcg - active: fluticasone propionate 0.5 g/kg ((micronised)) excipient: benzalkonium chloride dispersible cellulose glucose monohydrate phenethyl alcohol polysorbate 80 purified water

Canada - English - Health Canada

teva canada limited - fluticasone propionate - metered-dose pump - 50mcg - fluticasone propionate 50mcg - corticosteroids

Singapore - English - HSA (Health Sciences Authority)

pharmaforte singapore pte ltd - fluticasone propionate (micronized) - spray, metered - 0.05g/100g - fluticasone propionate (micronized) 0.05g/100g

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - salmeterol xinafoate, quantity: 0.0725 mg (equivalent: salmeterol, qty 0.05 mg); fluticasone propionate, quantity: 0.5 mg - inhalation, powder for - excipient ingredients: lactose monohydrate - for the regular treatment of asthma, where the use of a combination product is appropriate. this may include: ?patients on effective maintenance doses of long-acting beta-2 agonists and inhaled corticosteroids ?patients who are symptomatic on current inhaled corticosteroid therapy,for the symptomatic treatment of patients with severe copd (fev1 <50% predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular beta-2 agonist bronchodilator therapy. fluticasone salmeterol ciphaler 500/50 is not indicated for the initiation of bronchodilator therapy in copd.

Ireland - English - HPRA (Health Products Regulatory Authority)

haleon ireland limited - fluticasone propionate (micronised) - nasal spray, suspension - 50 mcg/acutuation - corticosteroids; fluticasone

United States - English - NLM (National Library of Medicine)

glaxosmithkline llc - fluticasone furoate (unii: js86977wnv) (fluticasone - unii:cut2w21n7u) - fluticasone furoate 27.5 ug - veramyst® (fluticasone furoate) nasal spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis in patients aged 2 years and older. veramyst nasal spray is contraindicated in patients with hypersensitivity to any of its ingredients [see warnings and precautions (5.3)] . teratogenic effects pregnancy category c. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. there were no teratogenic effects in rats and rabbits at inhaled fluticasone furoate dosages of up to 91 and 8 mcg/kg/day, respectively (approximately 7 and 1 times, respectively, the maximum recommended daily intranasal dose in adults on a mcg/m2 basis). there was also no effect on pre- or post-natal development in rats treated with up to 27 mcg/kg/day by inhalation during gestation and lactation (approximately 2 times the maximum recommended daily intranasal dose in adults on a mcg/m2 basis). there are no adequate and well-co

United States - English - NLM (National Library of Medicine)

clinical solutions wholesale - fluticasone propionate (unii: o2gmz0lf5w) (fluticasone - unii:cut2w21n7u) - fluticasone propionate 50 ug in 0.1 g

United States - English - NLM (National Library of Medicine)

cvs pharmacy - fluticasone propionate (unii: o2gmz0lf5w) (fluticasone - unii:cut2w21n7u) - fluticasone propionate 50 ug - allergy symptom reliever temporarily relieves these symptoms of hay fever or other upper respiratory allergies:

United States - English - NLM (National Library of Medicine)

puretek corporation - fluticasone propionate (unii: o2gmz0lf5w) (fluticasone - unii:cut2w21n7u) - fluticasone propionate 50 ug - fluticasone propionate nasal spray, usp is indicated for the management of the nasal symptoms of perennial nonallergic rhinitis in adult and pediatric patients aged 4 years and older. fluticasone propionate nasal spray is contraindicated in patients with hypersensitivity to any of its ingredients [see warnings and precautions ( 5.3), description ( 11)] . teratogenic effects pregnancy category c. there are no adequate and well-controlled trials with fluticasone propionate nasal spray in pregnant women. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. because animal reproduction studies are not always predictive of human response, fluticasone propionate nasal spray should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. women should be advised to contact their physicians if they become pregnant while taking fluticasone pro

United States - English - NLM (National Library of Medicine)

perrigo new york inc - fluticasone propionate (unii: o2gmz0lf5w) (fluticasone - unii:cut2w21n7u) - fluticasone propionate 50 ug